Frontiers in Pharmacology | Inflammation Pharmacology

Original Research

Published on 07 Jul 2025

Antagonizing IL-6 receptor restores pancreatic tissue resident NK cells activation and ameliorates pancreatic injury in the mouse model of MASH

in Inflammation Pharmacology

Johnny Amer
Diana Abu Arra
Ahmad Salhab
Faris Kayed
Muneer Maali
Raghad Shweiki
Mustafa Ghanim

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1611637

452 views

Correction

Accepted on 03 Jul 2025

Corrigendum: Berberine Ameliorates Subarachnoid Hemorrhage Injury via Induction of Sirtuin 1 and Inhibiting HMGB1/Nf-κB Pathway

in Inflammation Pharmacology

Xianghua Zhang
Lei Peng
Jing Zhang
Yipeng Dong
Chengjun Wang
Cang Liu
Da-Yong Xia
Xiangsheng Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1540873

119 views

Original Research

Accepted on 02 Jul 2025

Degradation of IRAK4 for the Treatment of Lipopolysaccharide induced acute lung injury in mice

in Inflammation Pharmacology

Bijun Ye
Shiyan Chen
Xiaohao Huang
Yinhong Qiu
Ruixiang Luo
Lulu Zheng

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1609923

127 views

Original Research

Published on 02 Jul 2025

Exploring the beneficial effects of GHK-Cu on an experimental model of colitis and the underlying mechanisms

in Inflammation Pharmacology

Shuzhen Mao
Jiahui Huang
Junyan Li
Fang Sun
Qilian Zhang
Qing Cheng
Wei Zeng
Dongya Lei
Shiyan Wang
Jing Yao

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1551843

365 views

Systematic Review

Published on 01 Jul 2025

Immunomodulatory effects of ulinastatin combined with continuous blood purification in sepsis: a systematic review and meta-analysis

in Inflammation Pharmacology

Hui Gao
Zhiqiang Tang
Shucheng Zhao
Yuanjun Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1591470

297 views

Correction

Published on 01 Jul 2025

Correction: Mechanism underlying the involvement of CXCR4/CXCL12 in diabetic wound healing and prospects for responsive hydrogel-loaded CXCR4 formulations

in Inflammation Pharmacology

Lingli Wang
Fengsong Nie
Zhaoyu Lu
Yang Chong

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1646006

386 views

Original Research

Accepted on 30 Jun 2025

Unique compound with anti-allergic action: inhibition of kinase activity of Lyn by KIRA6

in Inflammation Pharmacology

Goshi Matsushima
Yuri Matsui
Hanano Okamoto
Nagisa Umeda
Mai Kakimoto
Megumi Mino
Tadashi Nakagawa
Kaori Ishii
Yoshimi Matsuo
Daiki Matsubara

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1625798

102 views

Original Research

Published on 27 Jun 2025

Protective effects of Salubrinal against H2O2-induced muscle wasting via eIF2α/ATF4 signaling pathway

in Inflammation Pharmacology

Siming Lin
Jingying Wu
Guili Lian
Weibin Wu
Weixiao Chen
Ai Chen
Li Luo
Liangdi Xie

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1607606

325 views

Original Research

Accepted on 26 Jun 2025

Lumefantrine Ameliorates DSS-Induced Colitis by Targeting FLI-1 to Suppress NF-κB Signaling

in Inflammation Pharmacology

Ji Yang
Peng Guo
Hongtao Luo
Xin Tang
Wei Liu
Xiaolin Ren

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1614978

114 views

Review

Accepted on 25 Jun 2025

Research Progress in Treatment of Rheumatoid Arthritis with Sinomenine and Related Formulations Based on Different Administration Routes

in Inflammation Pharmacology

Wenya Wang
Zihui Wang
Aixia Ling
Chunyan Zhang
Mei Lv
Lufen Huang
Yanlian Niu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1613679

179 views

Original Research

Published on 25 Jun 2025

Impact of different treatment strategies on therapeutic efficacy and biomarkers in children with IVIG-resistant Kawasaki disease: a retrospective cohort study

in Inflammation Pharmacology

Xin Zhou
Rui Dong
Xiaoling Wei
Hao Ding
Xiaochen Wang
Wei Wu
Guiyun Kang
Lei Li
Xiang Ma

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1602637

388 views

Original Research

Published on 25 Jun 2025

Anti atherosclerosis effect and mechanism of a novel curcumin analogue CACN136: regulating macrophage M1/M2 polarization and lipid metabolism

in Inflammation Pharmacology

Qianjiao Zhao
Yueting Zhong
Zheng Li
Jia Tang
Chao Pi
Wenwu Zheng
Peng Shi
Ying Zuo
Jun Jiang
Yan Yang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1632647

388 views

Original Research

Published on 25 Jun 2025

Dexmedetomidine reduces acute lung injury caused by LPS through the SIRT3 signaling pathway in vivo

in Inflammation Pharmacology

Jian Chen
Yang Cai
Xiaochun Peng
Yuanling Xu
Liying Chen
Xinxin Pan
Yingying Sun

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1524219

281 views

Systematic Review

Published on 23 Jun 2025

Safety profile and dose-dependent adverse events of upadacitinib in randomized clinical trials: a systematic review and meta-analysis

in Inflammation Pharmacology

Cong Zhang
Zhiwen Fu
Jinmei Liu
Shijun Li
Xu Chen
Yi Zhang
Jiyi Xie

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1598972

538 views

Editorial

Published on 19 Jun 2025

Editorial: Purinergic signaling in metabolic diseases and inflammation pharmacology

in Inflammation Pharmacology

Alejandro Sánchez-Melgar
Juana Maria Sanz
Anna Lisa Giuliani

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1631388

504 views

Original Research

Published on 18 Jun 2025

Intracerebroventricular calycosin attenuates cerebral ischemia-reperfusion injury in rats via HMGB1-dependent pyroptosis inhibition

in Inflammation Pharmacology

Yuhui Zhang
Qiguang Wu
Yanjin Pan
Min Xin
Wenbo Wang
Xiaoya Zhai
Peiquan Zhou
Chong Zhang
Yong Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1596087

865 views